Drugs / WDVAX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01753089 | Jun 2013 → Aug 2025 | melanoma | Dana-Farber Cancer Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WDVAX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01753089 ↗ |
| Modality | Vaccine | “investigational melanoma vaccines” NCT01753089 ↗ |
| Route | Other | “implant the vaccine” NCT01753089 ↗ |